PROS1 and cancer: Over 50% of all human cancers harbor mutations and genetic alterations in cyclins and p53 genes directly affecting the function of critical cell cycle proteins, rendering the p53 gene ineffective in mediating cell growth arrest and promoting cancer cell death [62, 67, 68].